Search results
Kyverna's CAR-T relapse in lupus dents autoimmune hopes amid biotech gold rush
FierceBiotech· 19 hours agoA patient with lupus nephritis in a phase 1/2 clinical trial of Kyverna Therapeutics’ CAR-T...
Pfizer reports data from Phase II multiple myeloma treatment trial
Clinical Trials Arena via Yahoo Finance· 24 hours agoELREXFIO is a B-cell maturation antigen (BCMA...label, multicentre trial assessed ELREXFIO...
‘A ticking time bomb’: Grieving mother’s warning over deadly Chinese opioid epidemic
The Independent via Yahoo News· 14 hours agoAt up to 500 times stronger than morphine, even the most minute doses can prove fatal. But Dylan,...
How a well-traveled brain cancer drug turned into an $8 million payday for an East Bay firm - San...
The Business Journals· 14 hours agoA drug traded between companies for 20 years — and approved by regulators in April to treat brain...
Biotech With 345% Run Posts A 'Clear Win' In Cancer Treatment
Investor's Business Daily· 12 hours agoThe company tested its treatment, dubbed NX-5948, in patients with relapsed or refractory forms of...
FDA grants approval for Bristol Myers Squibb’s Augtyro for solid tumours
Pharmaceutical Technology via Yahoo Finance· 1 day agoIn May 2024, BMS received FDA approval for Breyanzi (lisocabtagene maraleucel; liso-cel) to treat...
EHA 2024: Odronextamab shows promise in ELM-2 study for follicular lymphoma
Clinical Trials Arena via Yahoo Finance· 17 hours agoRegeneron is continuing its extensive OLYMPIA programme, which includes Odronextamab, with ten...
FDA approves Amgen’s BLINCYTO for acute lymphoblastic leukaemia
Pharmaceutical Technology via Yahoo Finance· 24 hours agoIt is already approved in the US for multiple indications such as CD19-positive B-ALL in first or...
Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study
Zacks via Yahoo Finance· 18 hours agoRoche's (RHHBY) Columvi significantly extends survival in patients with relapsed or refractory...
...Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory...
Benzinga· 2 days agoDr. Kim Linton, M.B.Ch.B, MRCP, Ph.D., FRCP, senior lecturer at the ...